Site Supervisor - Atlanta

Sago•Atlanta, GA

1d•Onsite

About The Position

Sago, formerly Schlesinger Group, is a global research and data partner that connects human answers to business questions. They enable clients to solve business problems through extensive audience access and an adaptive range of qualitative and quantitative solutions, helping them understand what their customers want and demand to empower confident decisions. Sago seamlessly connects businesses to key insights. The company's work culture ranks high in happiness, work culture, and diversity compared to peers. The Site Supervisor provides day-to-day leadership and operational oversight for site staff supporting the PMTA study. This role holds primary accountability for site-level protocol execution, regulatory compliance, investigational product control, and staff performance.

Requirements

High school diploma required
Prior experience in clinical research, market research, or regulated study environments required

Nice To Haves

College degree preferred or equivalent relevant work experience
Previous supervisory or lead experience strongly preferred

Responsibilities

Provide direct supervision and day‑to‑day management of site staff supporting the PMTA study
Work with Facility Director/Manager to assign, oversee, and balance staff responsibilities to ensure adequate coverage for subject visits and study activities
Monitor staff performance and adherence to study protocols, SOPs, and regulatory requirements
Maintain overall responsibility for site‑level compliance with the study protocol, applicable SOPs, and regulatory requirements
Ensure informed consent is obtained and documented correctly for all subjects prior to any study‑related procedures
Oversee the accuracy, completeness, and maintenance of all regulated study documentation and source records
Oversee subject screening, enrollment, and retention activities to ensure consistent, compliant execution
Work with Clinical Project Management team to support complex subject interactions, escalated concerns, or compliance‑related issues